Industry

Sun Pharma inks pact with LIB Therapeutics to sell LDL-C drug

The Hindu - Industry·28 Sep 2026
Sun Pharma inks pact with LIB Therapeutics to sell LDL-C drug

Lerodalcibep is approved in the EU under the brand name Lyrokaul. In the U.S, it is FDA-approved under the brand name Lerochol

More news in Industry